Interview: access to richer data promises to usher in a new era of insight into patient heterogeneity

. 2013 Mar;2(2):109-12.

doi: 10.2217/cer.13.5.

Affiliations

Free article

Marc L Berger. J Comp Eff Res. 2013 Mar.

Free article

. 2013 Mar;2(2):109-12.

doi: 10.2217/cer.13.5.

¹ Pfizer, Inc, 235 East 42nd Street, New York, NY 10017, USA. marc.berger@pfizer.com.

No abstract available

Similar articles

From methods to policy: past as prologue: how comparative effectiveness research became patient-centered outcomes research.
Rich EC. Rich EC. J Comp Eff Res. 2012 Nov;1(6):475-7. doi: 10.2217/cer.12.59. J Comp Eff Res. 2012. PMID: 24236464 No abstract available.
Principles for planning and conducting comparative effectiveness research.
Luce BR, Drummond MF, Dubois RW, Neumann PJ, Jönsson B, Siebert U, Schwartz JS. Luce BR, et al. J Comp Eff Res. 2012 Sep;1(5):431-40. doi: 10.2217/cer.12.41. J Comp Eff Res. 2012. PMID: 24236420
[From comparative effectiveness research to patient-centered outcomes research].
Gerhardus A, Schmacke N. Gerhardus A, et al. Z Evid Fortbild Qual Gesundhwes. 2012;106(7):477-8. doi: 10.1016/j.zefq.2012.07.001. Epub 2012 Aug 11. Z Evid Fortbild Qual Gesundhwes. 2012. PMID: 22981022 German. No abstract available.
Optimizing the leveraging of real-world data to improve the development and use of medicines.
Berger ML, Lipset C, Gutteridge A, Axelsen K, Subedi P, Madigan D. Berger ML, et al. Value Health. 2015 Jan;18(1):127-30. doi: 10.1016/j.jval.2014.10.009. Epub 2014 Nov 27. Value Health. 2015. PMID: 25595243 Review.
From comparative effectiveness research to patient-centered outcomes research: policy history and future directions.
D'Arcy LP, Rich EC. D'Arcy LP, et al. Neurosurg Focus. 2012 Jul;33(1):E7. doi: 10.3171/2012.4.FOCUS12106. Neurosurg Focus. 2012. PMID: 22746239 Review.